Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NANLING roxadustat study in Chinese peritoneal dialysis patients with CKD anemia
ChiCTR2100044799Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of roxadustat in anemia of chronic kidney disease, sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Hemoglobin. Started Jan 2021; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR2100044799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044799.